Occupational Exposure to Antineoplastic Drugs

Displaying 1 - 1 of 1CSV
Gong, Z., Umoru, G., Monge, J., Shah, N., Mohyuddin, G. R., Radhakrishnan, S., Chakraborty, R., Schinke, C., D’Souza, A., & Mohan, M. (2023). Adverse Effects and Non-Relapse Mortality of BCMA-Directed Immunotherapies : An FDA Adverse Event Reporting System (FAERS) Database Study. Blood, 142(Supplement 1), 358–358. https://doi.org/10.1182/blood-2023-182695
Publication Date